Evidence map›Paper›PMID 31640194›Full record

ArticleBiomolecules2019

Synthesis of Novel Analogs of Thieno[2,3-

Sheng Zhang, Feize Liu, Xueling Hou, Jianguo Cao, Xiling Dai, Junjie Yu, Guozheng Huang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Enhancement of antitumor activity through structural optimization of 2-(Benzylamino)-thieno[2,3-d]pyrimidin-4(3H)-ones.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Article
  2. Review
  3. 2-Alkyl-Substituted-4-Amino-Thieno[2,3-Molecules (Basel, Switzerland) · 2023
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sheng ZhangCollege of Life Sciences, Shanghai Normal University, Shanghai 201418, China. zs534321312@foxmail.com.
Feize LiuKey Laboratory of Plant Resources and Chemistry of Arid Zone, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi 830011, China. feizeliu@yeah.net.
Xueling HouKey Laboratory of Plant Resources and Chemistry of Arid Zone, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi 830011, China. xlhou@ms.xjb.ac.cn.
Jianguo CaoCollege of Life Sciences, Shanghai Normal University, Shanghai 201418, China. cao101@shnu.edu.cn.
Xiling DaiCollege of Life Sciences, Shanghai Normal University, Shanghai 201418, China. daixiling2010@shnu.edu.cn.
Junjie YuCollege of Life Sciences, Shanghai Normal University, Shanghai 201418, China. 13621600677@163.com.
Guozheng HuangCollege of Life Sciences, Shanghai Normal University, Shanghai 201418, China. guozheng.huang@yahoo.com.ORCID 0000-0002-5730-9549

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

New 2,3-disubstituted thieno[2,3-

Indexed as

Antineoplastic AgentsApoptosisCell ProliferationCells, CulturedDrug Screening Assays, AntitumorHumansNeoplasmsPyrimidinonesAntineoplastic AgentsPyrimidinonesthieno(2,3-d)pyrimidin-4(3H)-oneanticancerthieno[2,3-d] pyrimidinonethienopyrimidine

Identifiers

PMID31640194
PMCPMC6843832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.